Efficacy and safety of MuShengshu in the treatment of mild-to-moderate atopic dermatitis: protocol for a randomized, double-blind, placebo-controlled trial - Top-Institutions - MDSpire

Efficacy and safety of MuShengshu in the treatment of mild-to-moderate atopic dermatitis: protocol for a randomized, double-blind, placebo-controlled trial

  • By

  • Xiangjin Gao

  • Ruiqi Cai

  • Jinrong Lu

  • Zhen Duan

  • Quanruo Xu

  • Xiuqi Zhang

  • Fanlingzi Shen

  • Rui Zhang

  • Bin Li

  • Ruiping Wang

  • May 21, 2026

  • 0 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    Shanghai Skin Disease Hospital
    Shanghai Skin Disease Hospital

    Shanghai, Shanghai

    Key Differentiators

    • Dermatology

Original Source(s)

Efficacy and safety of MuShengshu in the treatment of mild-to-moderate atopic dermatitis: protocol for a randomized, double-blind, placebo-controlled trial

  • by Xiangjin Gao, Ruiqi Cai, Jinrong Lu, Zhen Duan, Quanruo Xu, Xiuqi Zhang, Fanlingzi Shen, Rui Zhang, Bin Li, Ruiping Wang

  • May 21, 2026

Related Content

Toxic epidermal necrolysis induced by exposure to S,S-dimethyl cyanoimidodithiocarbonate: case report and nursing experience

Integrative analysis links traditional Chinese medicine syndrome differentiation to multi-dimensional skin phenotypes and predicts therapeutic response in photographs

3 Medical Routines That Older People May Not Need

“The treatment may be more burdensome than the condition itself."